Navigation Links
Preliminary Lineup of Presenters Set for 7th Annual New York Stem Cell Summit
Date:8/25/2011

PHILADELPHIA, Aug. 25, 2011 /PRNewswire/ -- RRY Publications LLC today announced the preliminary lineup of presenters for the 7th Annual Stem Cell Summit. The Stem Cell Summit, an intensive one-day event, that allows attendees to learn about the latest developments in the stem cell marketplace, evaluate the groundbreaking stem cell products physicians are using today, and discover the growing market potential in terms of revenues. For 2012, the Summit will feature 30+ presenters, a research review & debate session, and a special track on expanding the range of stem cell therapies.

The 7th Annual Stem Cell Summit will take place on Feb. 21, 2012, at Bridgewaters in the heart of New York City's historic South Street Seaport. The preliminary roster of companies and products featured will include representatives from 2011 presenters and new 2012 presenters.3DM, Inc.

Histogen Inc.Aastrom Biosciences, Inc.

Incell Corporation, LLCAldagen, Inc.

MaxCyte, Inc.AllCells, LLC

Moraga Biotechnology CorporationAlloSource

NeoStem, Inc.Amedica Corp.

Neuronyx, Inc.Arteriocyte, Inc.

Novocell, Inc.Bio Life Solutions Inc.

NuVasive, Inc.BioE Corp.

Osiris Therapeutics, Inc.BioTime Inc.

Parcell Laboratories LLCCalifornia Stem Cell, Inc.

Pervasis Therapeutics, Inc.Cognate BioServices, Inc.

Progenitor Cell Therapy, Inc.Cord Blood America, Inc.

StemagenCore Dynamics Ltd.

Stemina, Inc.Cytori Therapeutics, Inc.

TiGenix NVGamida Cell Ltd.

Tissue Genesis, Inc.Geron Corp.

Vet-Stem, Inc.Harvest Technologies Corp.In addition to the company and product overviews, Robin Young, president of RRY Publications and the organizer of the annual Stem Cell Summit, will deliver his updated 10-year market forecast for the industry.

7th Annual New York Stem Cell Summit Facts at a GlanceWhat:Largest Gathering of Stem Cell Company Executives, Scientists, Investors, and PhysiciansWhen:February 21, 2012Where: Bridgewaters11 Fulton StreetNew York CityWho:The Stem Cell Summit is organized by RRY Publications LLCAdmission:$750 advance registration by September 30, 2011$1,500 Registration (February 1, 2012 – February 21, 2012 and onsite)Information:For more information on presentation or sponsorship opportunities, call Bharathi Kavalipati at 610-260-6462 or send an email to bharathi@ryortho.comAdditional information, including attendee registration details, is available at www.stemcellsummit.comContacts:

Suzanne KirchnerRRY Publications LLC501-570-0328skirchner@ryortho.com
'/>"/>

SOURCE RRY Publications LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2011 Results
2. Generex Provides Preliminary Results of Generex Oral-lyn™ Clinical Trials in Patients with Type 1 Diabetes and Patients with Impaired Glucose Tolerance
3. Preliminary Results of a Large Scale Study Show ConvaTec Moldable Technology™ Skin Barriers Help to Prevent and Improve Peristomal Skin Issues in Ostomy Patients
4. Uroplasty on Preliminary List of Additions to Russell 3000® and Russell Global® Indexes
5. Delcath on Preliminary List of Additions to Russell Microcap® Index
6. LifeVantage Announces Preliminary Third Quarter 2011 Revenue
7. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
8. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
10. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
11. Symmetry Medical Announces Preliminary Unaudited Full Year 2010 Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):